Endoscopic stenting of the common bile duct allows successful treatment of a breast cancer patient with excessive liver metastases.
The treatment of a jaundiced patient with hyperbilirubinaemia due to breast cancer liver metastases is still a challenging problem. The associated hepatic dysfunction often represents a limiting factor for delivering standard dose chemotherapy. We report on the successful treatment of a jaundiced patient with excessive, recurrent liver metastases from breast cancer, using a combined chemotherapy of mitomycin and 5-fluorouracil after endoscopic stenting of the common bile duct.